Cryoport, Inc. SEC filings CYRX
Cryoport, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 15, 2008. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| S-8 | Employee stock plan registration | Jun 22, 2026 | — |
| 15-12G | Deregistration | Jun 22, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2026 | Jun 5, 2026 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 5, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2026 | Mar 3, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| UPLOAD | Letter from the SEC | Sep 8, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| NT 10-Q | Filing | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 5, 2025 |
| UPLOAD | Letter from the SEC | Jul 31, 2025 | — |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2025 | Jun 6, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Mar 7, 2025 | — |
| 10-K | Annual report | Mar 7, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2025 | Mar 4, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Aug 6, 2024 | Aug 1, 2024 |
| S-8 | Employee stock plan registration | Jun 14, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2024 | May 17, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| DEFA14A | Additional proxy material | Apr 3, 2024 | — |
| DEF 14A | Proxy statement | Apr 3, 2024 | May 17, 2024 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 15, 2024 | Feb 10, 2024 |
| 424B3 | Prospectus | Dec 21, 2023 | — |
| EFFECT | Filing | Dec 19, 2023 | — |
| POS AM | Filing | Dec 15, 2023 | — |
| POSASR | Filing | Dec 15, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 15, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 12, 2023 | Jul 12, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
May 16, 2023 | May 12, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 31, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2023 | Mar 24, 2023 |
| 8-K |
Current report
Auditor change
|
Mar 15, 2023 | Mar 9, 2023 |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 27, 2022 | — |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2022 | Apr 29, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2022 | Mar 15, 2022 |
| DEFA14A | Additional proxy material | Mar 18, 2022 | — |
| DEF 14A | Proxy statement | Mar 18, 2022 | Apr 29, 2022 |
| 8-K |
Current report
Other events
|
Mar 11, 2022 | Mar 11, 2022 |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Other events
|
Feb 9, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Other events
|
Feb 1, 2022 | Jan 31, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Nov 12, 2021 | Nov 12, 2021 |
| 424B5 | Prospectus supplement | Nov 12, 2021 | — |
| 8-K |
Current report
Other events
|
Nov 10, 2021 | Nov 9, 2021 |
| FWP | Free writing prospectus | Nov 10, 2021 | — |
| 8-K |
Current report
Other events
|
Nov 8, 2021 | Nov 8, 2021 |
| 424B5 | Prospectus supplement | Nov 8, 2021 | — |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| S-8 | Employee stock plan registration | Jun 24, 2021 | — |
| SD | Specialized disclosure (conflict minerals) | May 28, 2021 | — |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 5, 2021 | Apr 30, 2021 |
| 8-K |
Current report
Results of operations
|
May 4, 2021 | May 4, 2021 |
| DEFA14A | Additional proxy material | Apr 21, 2021 | — |
| DEFA14A | Additional proxy material | Mar 16, 2021 | — |
| DEF 14A | Proxy statement | Mar 16, 2021 | Apr 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2021 | Mar 1, 2021 |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Feb 8, 2021 | Feb 5, 2021 |
| 8-K |
Current report
Other events
|
Jan 25, 2021 | Jan 20, 2021 |
| 424B5 | Prospectus supplement | Jan 22, 2021 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jan 20, 2021 | Jan 19, 2021 |
| 424B5 | Prospectus supplement | Jan 19, 2021 | — |
| 8-K |
Current report
Other events
|
Jan 19, 2021 | Jan 19, 2021 |
| 8-K | Current report | Jan 19, 2021 | Jan 13, 2021 |
| S-3ASR | Automatic shelf registration | Dec 15, 2020 | — |
| 8-K/A | Amended current report | Dec 14, 2020 | Oct 1, 2020 |
| 10-Q | Quarterly report | Nov 6, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 1, 2020 | Oct 1, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Regulation FD disclosure
|
Aug 25, 2020 | Aug 24, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 21, 2020 | Aug 21, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2020 | Aug 6, 2020 |
| 25-NSE | Delisting notice | Jul 29, 2020 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 27, 2020 | May 26, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 21, 2020 | May 19, 2020 |
| 10-Q | Quarterly report | May 8, 2020 | Mar 31, 2020 |
| 8-K/A |
Amended current report
Results of operations
|
May 8, 2020 | May 7, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2020 | May 1, 2020 |
| DEF 14A | Proxy statement | Apr 3, 2020 | May 1, 2020 |
| 10-K | Annual report | Mar 10, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2020 | Mar 5, 2020 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Mar 3, 2020 | May 2, 2019 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2020 | Jan 9, 2020 |
| 8-K |
Current report
Unregistered share sale
|
Dec 19, 2019 | Dec 14, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 30, 2019 | Oct 28, 2019 |
| 8-K |
Current report
Other events
|
Oct 9, 2019 | Oct 9, 2019 |
| 8-K |
Current report
Auditor change
|
Aug 20, 2019 | Aug 15, 2019 |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Material agreement
|
Jul 10, 2019 | Jul 9, 2019 |
| 8-K |
Current report
Other events
|
Jun 24, 2019 | Jun 19, 2019 |
| 424B5 | Prospectus supplement | Jun 20, 2019 | — |
| 424B5 | Prospectus supplement | Jun 19, 2019 | — |
| 8-K/A | Amended current report | Jun 14, 2019 | May 14, 2019 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
May 14, 2019 | May 14, 2019 |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 3, 2019 | May 2, 2019 |
| 8-K |
Current report
Officer or director change
|
May 3, 2019 | May 2, 2019 |
| DEF 14A | Proxy statement | Apr 3, 2019 | May 2, 2019 |
| EFFECT | Filing | Mar 25, 2019 | — |
| CORRESP | Letter to the SEC | Mar 20, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2019 | — |
| S-3 | Shelf registration | Mar 13, 2019 | — |
| 10-K | Annual report | Mar 13, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2019 | Mar 7, 2019 |
| EFFECT | Filing | Feb 14, 2019 | — |
| CORRESP | Letter to the SEC | Feb 11, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2019 | — |
| S-3 | Shelf registration | Jan 28, 2019 | — |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2019 | Jan 4, 2019 |
| D/A | Filing | Dec 31, 2018 | — |
| D | Filing | Dec 28, 2018 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Dec 17, 2018 | Dec 14, 2018 |
| 10-Q | Quarterly report | Nov 8, 2018 | Sep 30, 2018 |
| UPLOAD | Letter from the SEC | Sep 11, 2018 | — |
| CORRESP | Letter to the SEC | Aug 31, 2018 | — |
| 8-K |
Current report
Material agreement
|
Aug 27, 2018 | Aug 24, 2018 |
| 424B5 | Prospectus supplement | Aug 27, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2018 | — |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| S-8 | Employee stock plan registration | Jun 1, 2018 | — |
| 8-K |
Current report
Shareholder vote results
|
May 18, 2018 | May 17, 2018 |
| 10-Q | Quarterly report | May 3, 2018 | Mar 31, 2018 |
| DEF 14A | Proxy statement | Apr 9, 2018 | May 17, 2018 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2018 | Mar 28, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2018 | Mar 30, 2018 |
| 10-K | Annual report | Mar 8, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2018 | Mar 6, 2018 |
| SC TO-I/A | Amendment no. 2 | Feb 8, 2018 | — |
| 8-K |
Current report
Other events
|
Feb 8, 2018 | Feb 8, 2018 |
| EFFECT | Filing | Feb 1, 2018 | — |
| 424B3 | Prospectus | Feb 1, 2018 | — |
| CORRESP | Letter to the SEC | Jan 30, 2018 | — |
| CORRESP | Letter to the SEC | Jan 22, 2018 | — |
| SC TO-I/A | Filing | Jan 22, 2018 | — |
| S-4/A | Filing | Jan 22, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2018 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 2, 2018 | Jan 2, 2018 |
| SC TO-I | Filing | Jan 2, 2018 | — |
| S-4 | Registration for a merger or exchange | Jan 2, 2018 | — |
| 8-K |
Current report
Material agreement
|
Dec 15, 2017 | Dec 15, 2017 |
| 10-Q | Quarterly report | Nov 2, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Oct 2, 2017 | — |
| EFFECT | Filing | Oct 2, 2017 | — |
| CORRESP | Letter to the SEC | Sep 29, 2017 | — |
| CORRESP | Letter to the SEC | Sep 29, 2017 | — |
| POS AM | Filing | Sep 22, 2017 | — |
| CORRESP | Letter to the SEC | Sep 22, 2017 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Brentwood, TN
- SEC filer status
- Accelerated filer
- SEC CIK
- 1124524
- Former names
- CRYOPORT SYSTEMS INC (until Oct 20, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.